PMDA
- Application: Xofluza Initial Approval
- Local brand name: Xofluza Initial Approval
- Status: approved
Xofluza (BALOXAVIR MARBOXIL) regulatory status in Japan.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA has authorised it; PMDA has authorised it.
Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.